BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 377943)

  • 1. Correlations of immunologic markers with histologic features of human non-Hodgkin's lymphomas.
    Brubaker DB; Whiteside TL; Hartsock RJ
    Am J Clin Pathol; 1979 Jun; 71(6):651-64. PubMed ID: 377943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation between benign and malignant human lymph nodes by means of immunologic markers.
    Brubaker DB; Whiteside TL
    Cancer; 1979 Apr; 43(4):1165-76. PubMed ID: 376086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunologic and cytochemical cell markers in non-Hodgkin's lymphomas.
    Davey FR; Goldberg J; Stockman J; Gottlieb AJ
    Lab Invest; 1976 Nov; 35(5):430-8. PubMed ID: 792563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant lymphomas of follicular center cell origin in man. I. Immunologic studies.
    Leech JH; Glick AD; Waldron JA; Flexner JM; Horn RG; Collins RD
    J Natl Cancer Inst; 1975 Jan; 54(1):11-21. PubMed ID: 1089792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunologic markers of non-Hodgkin's lymphomas.
    Berard CW; Jaffe ES; Braylan RC; Mann RB; Nanba K
    Recent Results Cancer Res; 1978; 64():138-45. PubMed ID: 366692
    [No Abstract]   [Full Text] [Related]  

  • 6. Surface markers and functional properties of non-Hodgkin's lymphoma cells in relation to histology.
    Bom-Van Noorloos AA; Splinter TA; van Heerde P; van Beek AA; Melief CJ
    Cancer; 1978 Oct; 42(4):1804-17. PubMed ID: 152144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of intracellular and cell surface immunoglobulin in non-Hodgkin's lymphoma.
    Davey FR; Halliday D; Marucci AA; Gottlieb AJ
    Hum Pathol; 1978 May; 9(3):285-94. PubMed ID: 350755
    [No Abstract]   [Full Text] [Related]  

  • 8. Characterization of non-Hodgkin's lymphomas using multiple cell markers. Immunologic, morphologic, and cytochemical studies of 72 cases.
    Pinkus GS; Said JW
    Am J Pathol; 1979 Feb; 94(2):349-80. PubMed ID: 311589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between the presence of surface localized immunoglobulin (Ig) and the histological type of human malignant lymphomas.
    Johansson B; Klein E; Haglund S
    Clin Immunol Immunopathol; 1976 Jan; 5(1):119-32. PubMed ID: 816584
    [No Abstract]   [Full Text] [Related]  

  • 10. Immune marker expression in 53 lymphomas of high-grade malignancy.
    Pallesen G; Madsen M; Schifter S
    Histopathology; 1983 Nov; 7(6):841-57. PubMed ID: 6689315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isoelectric focusing pattern of IgM and surface markers in non-Hodgkin's lymphomas.
    Stein H; Bouman H; Lennert K; Fuchs J; Havsteen B
    Haematol Blood Transfus; 1977; 20():315-27. PubMed ID: 344162
    [No Abstract]   [Full Text] [Related]  

  • 12. Lymphocyte surface characteristics in malignant lymphoma.
    Aisenberg AC; Long JC
    Am J Med; 1975 Mar; 58(3):300-6. PubMed ID: 1090157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunologic surface markers in non-Hodgkin's lymphomas.
    Cossman J; Schnitzer B; Deegan MJ
    Am J Pathol; 1977 Apr; 87(1):19-32. PubMed ID: 322504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of histologic and immunologic heterogeneity of non-Hodgkin's lymphomas.
    Borowitz MJ; Croker BP; Metzgar RS
    Am J Pathol; 1981 Nov; 105(2):97-106. PubMed ID: 6170233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of lymphocytic surface markers and histology in adult non-Hodgkin's lymphoma.
    Bloomfield CD; Kersey JH; Brunning RD; Gajl-Peczalska KJ
    Cancer Treat Rep; 1977 Sep; 61(6):963-70. PubMed ID: 332359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Canine malignant lymphomas: comparison of morphologic and immunologic parameters.
    Holmberg CA; Manning JS; Osburn BI
    J Natl Cancer Inst; 1976 Jan; 56(1):125-35. PubMed ID: 768497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. alpha-Naphthyl acetate esterase activity--a cytochemical marker for T lymphocytees. Correlation with immunologic studies of normal tissues, lymphocytic leukemias, non-Hodgkin's lymphomas, Hodgkin's disease, and other lymphoproliferative disorders.
    Pinkus GS; Hargreaves HK; McLeod JA; Nadler LM; Rosenthal DS; Said JW
    Am J Pathol; 1979 Oct; 97(1):17-41. PubMed ID: 315166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunologic and cytochemical properties of histiocytic and mixed histiocytic-lymphocytic lymphomas.
    Morris MW; Davey FR
    Am J Clin Pathol; 1975 Mar; 63(3):403-14. PubMed ID: 46698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-cell-rich lymphoproliferative disorders. Morphologic and immunologic differential diagnoses.
    Winberg CD; Sheibani K; Burke JS; Wu A; Rappaport H
    Cancer; 1988 Oct; 62(8):1539-55. PubMed ID: 2901904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunologic aspects and pathology of the malignant lymphomas.
    Berard CW; Jaffe ES; Braylan RC; Mann RB; Nanba K
    Cancer; 1978 Aug; 42(2 Suppl):911-21. PubMed ID: 356957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.